ATLANTA, Sept. 22, 2014 (GLOBE NEWSWIRE) -- MedAssets (Nasdaq:MDAS) today announced that it completed its previously announced acquisition of SG-2, LLC (Sg2), a leading provider of healthcare business intelligence, market analytics and clinical consulting services.
"Working with more than 1,400 hospitals and other clients across healthcare, Sg2's experts utilize software-as-a-service (SaaS)-based analytics tools and an intelligence platform to help healthcare organizations make informed strategic decisions related to acquisitions, service line extensions, market expansion, or other investments to optimize business growth," said John Bardis, chairman, president and CEO, MedAssets. "As a highly respected industry leader with superb market insight and forecasting capabilities, Sg2 creates a compelling combination with our proprietary cost, clinical, operational, claims reimbursement and episode-of-care datasets and tools to offer increased value for healthcare organizations and their leadership.
"We have invested in building out a robust advisory services and consulting practice, which is focused on cost management, clinical alignment, labor optimization, best practice processes and revenue cycle optimization to offer a pragmatic approach for fast and sustainable total performance improvement," Bardis continued. "We are excited to welcome Sg2 to the MedAssets team to augment our capabilities to help healthcare executives determine and successfully act upon future opportunities within dynamic local, regional and national markets."
Compelling Business Combination
Sg2 plays a key role in unlocking forecasting analytics and market insight to deliver optimal client value. The combination of Sg2 with MedAssets expands the depth of the company's performance improvement capabilities. Opportunities for future growth and business extensions include:
Transaction and Other Details
About MedAssets
MedAssets (Nasdaq:MDAS) is a healthcare performance improvement company focused on helping providers realize financial and operational gains so that they can sustainably serve the needs of their community. More than 4,400 hospitals and 122,000 non-acute healthcare providers currently use the company's evidence-based solutions, best practice processes and analytics to help reduce the total cost of care, enhance operational efficiency, align clinical delivery, and improve revenue performance across the care continuum. For more information, please visit www.medassets.com.
mdas/F